If you or someone you love has eczema, you know treating it can be frustrating. It takes a lot of trial and error to f ...

If you've been diagnosed with eczema, or atopic dermatitis, you're not alone. This chronic skin condition affects more than 31 million Americans and between 2 to 10 percent of adults worldwide, ...

Eczema, or atopic dermatitis, often worsens during seasonal changes like monsoon and autumn. Fluctuating humidity, allergens, ...

Besides mosquito bites, other causes of itchy bumps on your skin may include hives, other bug bites like flea bites, and ...

Constant loss of smell, facial pain and a blocked nose are a reality for the 10 per cent of people living with chronic ...

Data from the late-stage trial of amlitelimab weren’t as strong as the results seen in Phase 2, adding to doubts about a drug ...

Enveda has closed its second $150 million financing round of the year. The series D round, which moves Enveda’s total funding ...

Sanofi (SNY) stock drops after Phase 3 trial results for amlitelimab, its experimental therapy for eczema, disappointed ...

Eczema can be very distressing for children – and now it seems that its roots may at least partly lie in their mothers ...

LITTLE ROCK, AR (KATV) — Uterine fibroids, benign tumors that can cause significant discomfort, are in the spotlight this month as celebrities like ABC News Anchor Linsey Davis, singer Tamar Braxton, ...

The Health Canada approval is based on the results from the DELTA 1 and 2 clinical trials, which included 960 adult patients with moderate to severe CHE (20 per cent of which were Canadian). 2, 3 Both ...

The first few months of 2025 brought hope to the rare disease community. Food and Drug Administration leadership promised transparency and increased use of the accelerated approval pathway to deliver ...